Apellis Pharmaceuticals, Inc. (APLS)

24.65 +0.17 (+0.69%) USD  |  NASDAQ  |  Dec 19, 16:00
25.10 +0.45 (+1.83%) After-Hours: 20:00
More

Apellis Pharmaceuticals Unrealized Gain (Loss) on Investment Securities (Annual Per Share)

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade